🔵 [PAS 2026] - Can We Give Fewer Opioids to Babies With Withdrawal Syndrome?
The Incubator Channel · 26 Apr 2026 · 8 min
Summary
Dr Lori Devlin, principal investigator of the Optimize Now trial, presents results from a multicentre randomised trial comparing symptom-based opioid dosing with scheduled opioid tapers for neonatal opioid withdrawal syndrome, which reduced time to medical readiness for discharge and avoided scheduled tapers in many babies. She also previews the TREAT Now trial comparing buprenorphine with morphine and reflects on how Eat Sleep Console has changed care for these babies and families.
Third-party teaching is shown for education. Check it against your unit's guidance.